in-vitro population bioequivalence [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2019-02-06 09:55 (1896 d 09:57 ago) – Posting: # 19879
Views: 1,658

Hi kumarnaidu,

❝ We have conducted the Beclomethasone in-vitro population bioequivalence study for spray pattern test. Ten units for three batch of test and reference products were used for beginning life stage only.


❝ In this experiment, three reading were measured each canisters of beginning life stage only (m=1). My question is such case, n: Number of canisters or bottles per batch, for T and R products would be 10 or 30.


n is the number of units per batch; in this case it sounds like you have n=10. This is usually not enough to secure a reasonable chance to show BE for nasal products and inhaled products (regardless of pMDI, DPI or nebs).

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,651 registered users;
51 visitors (0 registered, 51 guests [including 6 identified bots]).
Forum time: 20:53 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5